Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Complement Activation Is Associated with Endothelial Damage in Hematopoietic Stem Cell Transplant Associated-Thrombotic Microangiopathy

Paula M Jacobi, Roxanne Cofiell, C-Hong Chang, SungKwon Kim, Sarah E Sartain

Blood (2022) 140 (Supplement 1): 5522–5524.

https://doi.org/10.1182/blood-2022-163213

Published: 2022

Journal Articles

Von Willebrand Factor Activates the Alternative Complement Pathway In Vivo in a Mouse Model of Complement Thrombotic Microangiopathy

Paula M Jacobi, Sarah E Sartain, MD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-141240

Published: 2020

Journal Articles

Whole-exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease

Karl C. Desch, Ayse B. Ozel, Matt Halvorsen, Paula M. Jacobi, Krista Golden, Mary Underwood, Marine Germain, David-Alexandre Tregouet, Pieter H. Reitsma, Clive Kearon, Lauren Mokry, J. Brent Richards, Frances Williams, Jun Z. Li, David Goldstein, David Ginsburg

Blood (2020) 136 (5): 533–541.

https://doi.org/10.1182/blood.2019004161

Published: 2020

Includes: Supplemental data

Journal Articles

Exome Sequencing in Venous Thromboembolic Disease Identifies Excess Mutation Burden in PROS1, PROC, SERPINC1 and STAB2

Karl C. Desch, MD, Ayse Bilge Ozel, PhD, Matt Halvorsen, PhD, Paula M. Jacobi, Marine Germain, PhD, David Alexandre Tregouet, PhD, Pieter H. Reitsma, David Goldstein, PhD, David Ginsburg, MD

Blood (2016) 128 (22): 3794.

https://doi.org/10.1182/blood.V128.22.3794.3794

Published: 2016

Journal Articles

Crucial role for the VWF A1 domain in binding to type IV collagen

Veronica H. Flood, Abraham C. Schlauderaff, Sandra L. Haberichter, Tricia L. Slobodianuk, Paula M. Jacobi, Daniel B. Bellissimo, Pamela A. Christopherson, Kenneth D. Friedman, Joan Cox Gill, Raymond G. Hoffmann, Robert R. Montgomery, the Zimmerman Program Investigators

Blood (2015) 125 (14): 2297–2304.

https://doi.org/10.1182/blood-2014-11-610824

Published: 2015

Journal Articles

A Native Whole Blood Thrombin Generation Assay Allows Discrimination of Whole Blood Samples with FVIII Levels below 1%

Christina K Baumgartner, Jonathan C Roberts, Paula M Jacobi, Sandra L Haberichter, Qizhen Shi, Robert R. Montgomery, MD

Blood (2014) 124 (21): 4215.

https://doi.org/10.1182/blood.V124.21.4215.4215

Published: 2014

Journal Articles

Development and Validation of a Chromogenic Direct Thrombin Inhibitor Assay on the ACL Top 700 for Quantifying Dabigatran Levels in Plasma

Paula M Jacobi, Sharniece Covill, Andrew S Podd, PhD, Kenneth D Friedman, MD, Sandra L Haberichter, PhD

Blood (2014) 124 (21): 1548.

https://doi.org/10.1182/blood.V124.21.1548.1548

Published: 2014

Journal Articles

Upstream Mechanisms Causing Type 1C Von Willebrand Disease (VWD): Contribution Of Defective Von Willebrand Factor (VWF) Multimerization, Regulated Storage, and Secretion

Sandra L. Haberichter, David A Jakab, Paula M. Jacobi

Blood (2013) 122 (21): 3571.

https://doi.org/10.1182/blood.V122.21.3571.3571

Published: 2013

Journal Articles

VWF Interaction With Type IV Collagen Is Mediated Through Critical VWF A1 Domain Residues

Veronica H. Flood, MD, Abraham C. Schlauderaff, Paula M. Jacobi, Tricia L. Slobodianuk, Robert R. Montgomery, MD, Sandra L. Haberichter, The Zimmerman Program Investigators

Blood (2013) 122 (21): 29.

https://doi.org/10.1182/blood.V122.21.29.29

Published: 2013

Journal Articles

A New Microfluidic-Based Platelet Rolling Assay to Better Characterize VWD Phenotypes

Tara C White-Adams, PhD, Paula M Jacobi, BA, Sandra L Haberichter, PhD, Keith B Neeves, PhD, Jorge A Di Paola, MD

Blood (2012) 120 (21): 3386.

https://doi.org/10.1182/blood.V120.21.3386.3386

Published: 2012

Journal Articles

Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage

Paula M. Jacobi, Joan Cox Gill, Veronica H. Flood, David A. Jakab, Kenneth D. Friedman, Sandra L. Haberichter

Blood (2012) 119 (19): 4543–4553.

https://doi.org/10.1182/blood-2011-06-360875

Published: 2012

Includes: Supplemental data

Journal Articles

Von Willebrand Factor Collagen Binding Provides a Sensitive Screen for Identification of Type 2A and 2B Von Willebrand Disease

Veronica H Flood, MD, Joan Cox Gill, MD, Kenneth D Friedman, MD, Pamela A Christopherson, Paula M. Jacobi, BS, Robert R. Montgomery, MD, Sandra L Haberichter, PhD

Blood (2011) 118 (21): 379.

https://doi.org/10.1182/blood.V118.21.379.379

Published: 2011

Journal Articles

Molecular Analysis of Type 1 VWD Mutations: Effects of Mutant:Wild-Type Transfection Ratio and Protein Degradation

Tara C White-Adams, PhD, Paula M Jacobi, BA, Sandra L Haberichter, PhD, Jorge A Di Paola, MD

Blood (2011) 118 (21): 1210.

https://doi.org/10.1182/blood.V118.21.1210.1210

Published: 2011

Journal Articles

Quantitative Analysis of VWF Multimer Structure: Discrimination Between VWD Subtypes

Sandra L Haberichter, PhD, Paula M Jacobi, BA, Veronica H Flood, MD, Pamela A. Christopherson, Joan Cox Gill, MD, Daniel B. Bellissimo, PhD, Kenneth D Friedman, MD, The Zimmerman Program Investigators

Blood (2011) 118 (21): 1215.

https://doi.org/10.1182/blood.V118.21.1215.1215

Published: 2011

Journal Articles

De Novo Synthesis & Storage of Human Factor VIII In Platelets Reduces Bleeding In Canine Hemophilia A

Lily M. Du, MD, Helen W.G. Franck, BS, Elizabeth P. Merricks, PhD, Paquita Nurden, MD, Eric S. Jensen, DVM, Sandra L. Haberichter, PhD, Troy B. Hawkins, PhD, Paula M. Jacobi, BS, Juan Fang, MD, Timothy C. Nichols, MD, Sevasti B. Koukouritaki, PhD, Qizhen Shi, MD, PhD, Robert R. Montgomery, MD, Kenneth Cornetta, MD, Alan T. Nurden, PhD, David A. Wilcox, PhD

Blood (2010) 116 (21): 2198.

https://doi.org/10.1182/blood.V116.21.2198.2198

Published: 2010

Journal Articles

Reduced Von Willebrand Factor Secretion Is Associated with Loss of Weibel-Palade Formation

Giancarlo Castaman, MD, Sofia Helene Giacomelli, Paula M. Jacobi, BS, Tobias Obser, Reinhard Schneppenheim, MD, PhD, Sandra L Haberichter, PhD

Blood (2010) 116 (21): 541.

https://doi.org/10.1182/blood.V116.21.541.541

Published: 2010

Journal Articles

Platelet-Targeted Expression of Human BDD-FVIII Reduces Bleeding in Canine Hemophilia A.

Lily M. Du, MS, MD, Timothy C. Nichols, MD, Sandra L. Haberichter, PhD, Paula M. Jacobi, Eric S. Jensen, DVM, Juan Fang, MD, Qizhen Shi, MD, PhD, Robert R. Montgomery, MD, David A. Wilcox, PhD

Blood (2009) 114 (22): 691.

https://doi.org/10.1182/blood.V114.22.691.691

Published: 2009

Journal Articles

Intersection of Mechanisms of Type 2A Von Willebrand Disease through Defects in Von Willebrand Factor Multimerization, Secretion, ADAMTS-13 Susceptibility, and Regulated Storage

Paula M. Jacobi, Joan Cox Gill, MD, Kenneth D. Friedman, MD, Robert R. Montgomery, MD, Sandra L. Haberichter, PhD

Blood (2008) 112 (11): 588.

https://doi.org/10.1182/blood.V112.11.588.588

Published: 2008

Journal Articles

Platelet-Targeted Expression of Coagulation Factor VIII (FVIII) Shows Efficacy for Using the Dog as a Large Animal Model for Gene Therapy of Hemophilia a

David A. Wilcox, PhD, Lily M. Du, MS, MD, Sandra L. Haberichter, PhD, Paula M. Jacobi, Juan Fang, MD, Eric S. Jensen, DVM, Qizhen Shi, MD, PhD, Robert R. Montgomery, MD

Blood (2008) 112 (11): 3525.

https://doi.org/10.1182/blood.V112.11.3525.3525

Published: 2008

NARROW

Complement Activation Is Associated with Endothelial Damage in Hematopoietic Stem Cell Transplant Associated-Thrombotic Microangiopathy

Von Willebrand Factor Activates the Alternative Complement Pathway In Vivo in a Mouse Model of Complement Thrombotic Microangiopathy

Whole-exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease

Exome Sequencing in Venous Thromboembolic Disease Identifies Excess Mutation Burden in PROS1, PROC, SERPINC1 and STAB2

Crucial role for the VWF A1 domain in binding to type IV collagen

A Native Whole Blood Thrombin Generation Assay Allows Discrimination of Whole Blood Samples with FVIII Levels below 1%

Development and Validation of a Chromogenic Direct Thrombin Inhibitor Assay on the ACL Top 700 for Quantifying Dabigatran Levels in Plasma

Upstream Mechanisms Causing Type 1C Von Willebrand Disease (VWD): Contribution Of Defective Von Willebrand Factor (VWF) Multimerization, Regulated Storage, and Secretion

VWF Interaction With Type IV Collagen Is Mediated Through Critical VWF A1 Domain Residues

A New Microfluidic-Based Platelet Rolling Assay to Better Characterize VWD Phenotypes

Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage

Von Willebrand Factor Collagen Binding Provides a Sensitive Screen for Identification of Type 2A and 2B Von Willebrand Disease

Molecular Analysis of Type 1 VWD Mutations: Effects of Mutant:Wild-Type Transfection Ratio and Protein Degradation

Quantitative Analysis of VWF Multimer Structure: Discrimination Between VWD Subtypes

De Novo Synthesis & Storage of Human Factor VIII In Platelets Reduces Bleeding In Canine Hemophilia A

Reduced Von Willebrand Factor Secretion Is Associated with Loss of Weibel-Palade Formation

Platelet-Targeted Expression of Human BDD-FVIII Reduces Bleeding in Canine Hemophilia A.

Intersection of Mechanisms of Type 2A Von Willebrand Disease through Defects in Von Willebrand Factor Multimerization, Secretion, ADAMTS-13 Susceptibility, and Regulated Storage

Platelet-Targeted Expression of Coagulation Factor VIII (FVIII) Shows Efficacy for Using the Dog as a Large Animal Model for Gene Therapy of Hemophilia a

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only